A phase 2 randomized study of TAS-102 versus topotecan or...

Lung Cancer 2016 / 10 Vol. 100

A phase 2 randomized study of TAS-102 versus topotecan or amrubicin in patients requiring second-line chemotherapy for small cell lung cancer refractory or sensitive to frontline platinum-based chemotherapy

Scagliotti, Giorgio, Nishio, Makoto, Satouchi, Miyako, Valmadre, Giuseppe, Niho, Seiji, Galetta, Domenico, Cortinovis, Diego, Benedetti, Fabio, Yoshihara, Eiji, Makris, Lukas, Inoue, Akira, Kubota, Ka
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
100
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2016.06.023
Date:
October, 2016
File:
PDF, 391 KB
english, 2016
Conversion to is in progress
Conversion to is failed